Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Shares Outstanding (Diluted Average) (2018 - 2024)

Catalyst Pharmaceuticals filings provide 7 years of Shares Outstanding (Diluted Average) readings, the most recent being $123.4 million for Q1 2024.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 8.26% to $123.4 million in Q1 2024 year-over-year; TTM through Mar 2024 was $123.4 million, a 8.26% increase, with the full-year FY2023 number at $113.8 million, up 2.13% from a year prior.
  • Shares Outstanding (Diluted Average) hit $123.4 million in Q1 2024 for Catalyst Pharmaceuticals, up from $113.8 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $123.4 million in Q1 2024 to a low of $106.2 million in Q4 2020.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $107.8 million (2021), compared with a mean of $109.9 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): fell 4.84% in 2023 and later increased 8.26% in 2024.
  • Catalyst Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $106.2 million in 2020, then grew by 1.46% to $107.8 million in 2021, then grew by 3.32% to $111.4 million in 2022, then rose by 2.13% to $113.8 million in 2023, then grew by 8.48% to $123.4 million in 2024.
  • The last three reported values for Shares Outstanding (Diluted Average) were $123.4 million (Q1 2024), $113.8 million (Q4 2023), and $106.6 million (Q3 2023) per Business Quant data.